Elevated AKT activity is commonly seen in metastatic tumors and continues to be a topic under intense research since AKT makes important contributions both to the invasive behavior of the cells and to their resistance to anti-tumor medical treatment [83]. This evidence concerns the gene AKT1 and metastatic neoplasm.